Near-infrared fluorescence sentinel lymph node mapping in breast cancer: A multicenter experience

Breast Cancer Research and Treatment

Volumn 143, Issue 2, 2014, Pages 333-342

  Verbeek, Floris P R ^a   Troyan, Susan L ^b   Mieog, J Sven D ^a   Liefers, Gerrit Jan ^a   Moffitt, Lorissa A ^c   Rosenberg, Mireille ^c   Hirshfield Bartek, Judith ^b   Gioux, Sylvain ^c   Van De Velde, Cornelis J H ^a   Vahrmeijer, Alexander L ^a   Frangioni, John V ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Indocyanine green; Near infrared fluorescence; Sentinel lymph node mapping

Indexed keywords

ANTINEOPLASTIC AGENT; COLLOID TC 99M; INDOCYANINE GREEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CAMERA; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER STAGING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLUORESCENCE IMAGING; GOLD STANDARD; HUMAN; HUMAN TISSUE; IMAGING SYSTEM; IN VIVO STUDY; INTERMETHOD COMPARISON; INTRAOPERATIVE PERIOD; LYMPH NODE DISSECTION; MACROMETASTASIS; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; METASTASIS RESECTION; MIDDLE AGED; MULTICENTER STUDY; NEAR INFRARED IMAGING SYSTEM; NETHERLANDS; PATIENT SAFETY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIOACTIVITY; SENTINEL LYMPH NODE BIOPSY; SENTINEL LYMPH NODE METASTASIS; UNIVERSITY HOSPITAL; VALIDATION STUDY; VERY ELDERLY; BREAST NEOPLASMS; CLINICAL TRIAL; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; FLUORESCENCE; INFRARED RADIATION; LYMPH NODE; LYMPH VESSEL; LYMPHATIC METASTASIS; PATHOLOGY; PROCEDURES; RADIOGRAPHY;

ADULT; AGED; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; FEMALE; FLUORESCENCE; HUMANS; INDOCYANINE GREEN; INFRARED RAYS; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHATIC VESSELS; MIDDLE AGED;

EID: 84893138665     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-013-2802-9     Document Type: Article

References (35)

1. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, Ku NN, Lyman GH, Berman C, Haddad F, Reintgen DS (1998) Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 227:645-651
2. Goyal A, Newcombe RG, Chhabra A, Mansel RE (2006) Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer: results of the ALMANAC validation phase. Breast Cancer Res Treat 99:203-208
3. Krag DN, Anderson SJ, Julian TB, Brown AM, Harlow SP, Ashikaga T, Weaver DL, Miller BJ, Jalovec LM, Frazier TG, Noyes RD, Robidoux A, Scarth HM, Mammolito DM, McCready DR, Mamounas EP, Costantino JP, Wolmark N (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8:881-888
4. Zavagno G, De Salvo GL, Scalco G, Bozza F, Barutta L, Del BP, Renier M, Racano C, Carraro P, Nitti D (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247:207-213
5. Straver ME, Meijnen P, van Tienhoven G, van de Velde CJ, Mansel RE, Bogaerts J, Duez N, Cataliotti L, Klinkenbijl JH, Westenberg HA, van der Mijle H, Snoj M, Hurkmans C, Rutgers EJ (2010) Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial. Ann Surg Oncol 17:1854-1861
6. Mansel RE, MacNeill F, Horgan K, Goyal A, Britten A, Townson J, Clarke D, Newcombe RG, Keshtgar M, Kissin M, Layer G, Hilson A, Ell P, Wishart G, Brown D, West N (2013) Results of a national training programme in sentinel lymph node biopsy for breast cancer. Br J Surg 100:654-661
7. Reyes F, Noelck M, Valentino C, Grasso-Lebeau L, Lang J (2010) Complications of methylene blue dye in breast surgery: case reports and review of the literature. J Cancer 2:20-25
8. Zakaria S, Hoskin TL, Degnim AC (2008) Safety and technical success of methylene blue dye for lymphatic mapping in breast cancer. Am J Surg 196:228-233
9. Pesek S, Ashikaga T, Krag LE, Krag D (2012) The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis. World J Surg 36:2239-2251
10. Hojo T, Nagao T, Kikuyama M, Akashi S, Kinoshita T (2010) Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer. Breast 19:210-213
11. Tagaya N, Aoyagi H, Nakagawa A, Abe A, Iwasaki Y, Tachibana M, Kubota K (2011) A novel approach for sentinel lymph node identification using fluorescence imaging and image overlay navigation surgery in patients with breast cancer. World J Surg 35:154-158
12. Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K, Suwa H, Ikeda T, Yoshimura K, Niimi M, Shimizu A, Toi M (2013) Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol 20:2213-2218
13. Takeuchi M, Sugie T, Abdelazeem K, Kato H, Shinkura N, Takada M, Yamashiro H, Ueno T, Toi M (2012) Lymphatic mapping with fluorescence navigation using indocyanine green and axillary surgery in patients with primary breast cancer. Breast J 18:535-541
14. Hirano A, Kamimura M, Ogura K, Kim N, Hattori A, Setoguchi Y, Okubo F, Inoue H, Miyamoto R, Kinoshita J, Fujibayashi M, Shimizu T (2012) A comparison of indocyanine green fluorescence imaging plus blue dye and blue dye alone for sentinel node navigation surgery in breast cancer patients. Ann Surg Oncol 19:4112-4116
15. Wishart GC, Loh SW, Jones L, Benson JR (2012) A feasibility study (ICG-10) of indocyanine green (ICG) fluorescence mapping for sentinel lymph node detection in early breast cancer. Eur J Surg Oncol 38:651-656
16. Aoyama K, Kamio T, Ohchi T, Nishizawa M, Kameoka S (2011) Sentinel lymph node biopsy for breast cancer patients using fluorescence navigation with indocyanine green. World J Surg Oncol 9:157
17. Abe H, Mori T, Umeda T, Tanaka M, Kawai Y, Shimizu T, Cho H, Kubota Y, Kurumi Y, Tani T (2011) Indocyanine green fluorescence imaging system for sentinel lymph node biopsies in early breast cancer patients. Surg Today 41:197-202
18. Kitai T, Kawashima M (2011) Transcutaneous detection and direct approach to the sentinel node using axillary compression technique in ICG fluorescence-navigated sentinel node biopsy for breast cancer. Breast Cancer 19:343-348
19. 99mTechnetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients. Ann Surg Oncol 19:4104-4111
20. Schaafsma BE, Verbeek FP, Rietbergen DD, van der Hiel B, van der Vorst JR, Liefers GJ, Frangioni JV, van de Velde CJ, van Leeuwen FW, Vahrmeijer AL (2013) Clinical trial of combined radio- and fluorescence-guided sentinel lymph node biopsy in breast cancer. Br J Surg 100:1037-1044
21. Mieog JS, Troyan SL, Hutteman M, Donohoe KJ, van der Vorst JR, Stockdale A, Liefers GJ, Choi HS, Gibbs-Strauss SL, Putter H, Gioux S, Kuppen PJ, Ashitate Y, Lowik CW, Smit VT, Oketokoun R, Ngo LH, van de Velde CJ, Frangioni JV, Vahrmeijer AL (2011) Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol 18:2483-2491
22. Hutteman M, Mieog JS, van der Vorst JR, Liefers GJ, Putter H, Lowik CW, Frangioni JV, van de Velde CJ, Vahrmeijer AL (2011) Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat 127:163-170
23. Hirche C, Murawa D, Mohr Z, Kneif S, Hunerbein M (2010) ICG fluorescence-guided sentinel node biopsy for axillary nodal staging in breast cancer. Breast Cancer Res Treat 121:373-378
24. Frangioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7:626-634
25. Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV (2013) Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol 10(9):507-518
26. Fujisawa Y, Nakamura Y, Kawachi Y, Otsuka F (2012) Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer. J Surg Oncol 106:41-45
27. Blum KS, Proulx ST, Luciani P, Leroux JC, Detmar M (2013) Dynamics of lymphatic regeneration and flow patterns after lymph node dissection. Breast Cancer Res Treat 139:81-86
28. Gioux S, Choi HS, Frangioni JV (2010) Image-guided surgery using invisible near-infrared light: fundamentals of clinical translation. Mol Imaging 9:237-255
29. Kiluk JV, Ly QP, Santillan AA, Meade T, Ramos D, Reintgen DS, Dessureault S, Davis M, Shamehdi C, Cox CE (2010) Erratum to: axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up. Ann Surg Oncol 17:552-557
30. Benya R, Quintana J, Brundage B (1989) Adverse reactions to indocyanine green: a case report and a review of the literature. Cathet Cardiovasc Diagn 17:231-233
31. Bezu C, Coutant C, Salengro A, Darai E, Rouzier R, Uzan S (2011) Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol 20:e55-e59
32. Alford R, Simpson HM, Duberman J, Hill GC, Ogawa M, Regino C, Kobayashi H, Choyke PL (2009) Toxicity of organic fluorophores used in molecular imaging: literature review. Mol Imaging 8:341-354
33. Ohnishi S, Lomnes SJ, Laurence RG, Gogbashian A, Mariani G, Frangioni JV (2005) Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging 4:172-181
34. Rajagopalan R, Uetrecht P, Bugaj JE, Achilefu SA, Dorshow RB (2000) Stabilization of the optical tracer agent indocyanine green using noncovalent interactions. Photochem Photobiol 71:347-350
35. Tagaya N, Nakagawa A, Abe A, Iwasaki Y, Kubota K (2010) Non-invasive identification of sentinel lymph nodes using indocyanine green fluorescence imaging in patients with breast cancer. Open Surg Oncol J 2:71-74